New FTC Report Exposes Pharmacy Benefit Managers' Secretive Practices in U.S. Healthcare

Benzinga

The Federal Trade Commission has released a critical interim report highlighting the substantial influence and opaque practices of pharmacy benefit managers in the U.S. healthcare system. These intermediaries, including CVS Caremark, Express Scripts, and Optum Rx, manage prescription drug benefits and wield significant power through negotiations and control of drug access. The report suggests that PBMs inflate drug costs and disadvantage independent pharmacies, steering profits towards their affiliated entities.

Transcript

00:00It's Benzinga, and here's what's on the block.

00:02The Federal Trade Commission has released a critical interim report highlighting the

00:06substantial influence and opaque practices of pharmacy benefit managers in the U.S. health

00:11care system.

00:12These intermediaries, including CVS, Caremark, Express Scripts, and OptumRx, manage prescription

00:18drug benefits and wield significant power through negotiations and control of drug access.

00:23The report suggests that PBMs inflate drug costs and disadvantage independent pharmacies,

00:29steering profits toward their affiliated entities.

00:31For all things money, visit Benzinga.com.

Category

Transcript

Comments

Recommended